WebThe NeoTYPE Lymphoid Disorders Profile detects DNA mutations (SNVs and InDels) in 128 genes across multiple lymphoma/leukemia subtypes through next-generation sequencing (NGS): ABL1, ABL2, ALK, ARHGEF1, ARID1A, ARID2, ASXL1, ATM, B2M, BCL2, BCL6, BCOR, BIRC3, BRAF, BTK, CARD11, CCND1, CCND2, CCND3, CD274, CD79A, … WebMyeloproliferative Neoplasm (MPN) Panel; Personalized Genomic Medicine. ... Next-generation sequencing (NGS) Turnaround Time: 14 days: Samples tested: Blood, bone …
Next-Generation Sequencing-Based Panel Testing for Myeloid …
Web12 feb. 2024 · Kristin Hunt Karner, MD, brings her expertise to ARUP diagnostics every day. A medical director for two ARUP departments, Hematopathology and Molecular … Web5 apr. 2024 · The Neo Comprehensive™ - Myeloid Disorders Profile is a recently debuted assay that utilizes next-generation sequencing (NGS) to detect alterations in 164… ogs st michael
Marcus B. Silva, JD, MBA auf LinkedIn: NeoGenomics Laboratories …
WebThe Neo Comprehensive™ - Myeloid Disorders Profile utilizes next-generation sequencing (NGS) to detect alterations in 164 genes relevant to a spectrum of myeloid diseases, including acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), chronic myelomonocytic leukemia (CMML), and more. WebThe Neo Comprehensive™ - Myeloid Disorders Profile utilizes next-generation sequencing (NGS) to detect alterations in 164 genes relevant to a spectrum of… Marcus B. Silva, JD, MBA auf LinkedIn: NeoGenomics Laboratories on LinkedIn: The Neo Comprehensive™ - … Web13 mrt. 2024 · Neo Comprehensive - Myeloid Disorders is available as an enhancement of NeoGenomics' previous Myeloid panel, making it the largest DNA and RNA NGS myeloid panel on the market with the most ... ogs stock dividend history